The United States Supreme Court indefinitely extended telehealth access to the abortion medication mifepristone on May 14, pending further litigation in federal court. While the challenge to telehealth access comes from Louisiana, the case has already resulted in nationwide impacts—including states with abortion protections, like Virginia. Louisiana argues that a 2023 U.S. Food and Drug … Continue reading SCOTUS stays circuit court’s block of telehealth mifepristone access